Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.-Reference-Cited by-同舟云学术

Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.

Published:1998-03 Issue:5 Volume:81 Page:582-587
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Jones Peter,Kafonek Stephanie,Laurora Irene,Hunninghake Donald

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference27 articles.

1. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II);JAMA,1993

2. Once-daily pravastatin in patients with primary hypercholesterolemia;Jones;Clin Cardiol,1991

3. HMG CoA reducatase inhibitors;Illingworth;Curr Opin Lipidol,1991

4. A review of clinical trials comparing HMG CoA reductase inhibitors;Illingworth;Clin Ther,1994

5. Comparison of the effects on quality of life and the efficacy and tolerability of lovastatin versus pravastatin;Weir;Am J Cardiol,1996

Cited by 932 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy;Frontiers in Endocrinology;2024-07-30

2. Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation;PLOS ONE;2024-05-02

3. Low-Intensity Statin Plus Ezetimibe Versus Moderate-Intensity Statin for Primary Prevention: A Population-Based Retrospective Cohort Study in Asian Population;Annals of Pharmacotherapy;2024-03-20

4. An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma;2024-01-31

5. The effect of Melissa officinalis on diet-induced hyperlipidemia, hypercholesterolemia, oxidative stress and inflammation;Journal of the Hellenic Veterinary Medical Society;2024-01-18